SEATTLE, WA--(Marketwired - Mar 24, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that it will issue financial results and corporate developments for the fiscal year ended December 31, 2013, following the close of market on Thursday, March 27, 2014.

Management will host a conference call on Thursday, March 27, 2014, at 4:45 pm Eastern Time to review financial results and corporate highlights. Following management's formal remarks, there will be a question and answer session.

To listen to the call by phone, interested parties within the U.S. should call 866-652-5200. International callers should call 412-317-6060. All callers should ask for the Atossa Genetics conference call. The conference call will also be available through a live webcast at

A replay of the call will be available approximately one hour after the end of the call through April 27, 2014. The replay can be accessed via Atossa's website or by dialing 866-250-8117 (domestic) or 412-317-6011 (international). The replay conference ID number is 10041148.

About Atossa Genetics

Atossa Genetics Inc. is focused on improving breast health through the development of laboratory developed tests (LDTs), medical devices and therapeutics. The Company's LDTs are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc., (the NRLBH). The LDT's and the Company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For additional information, please visit

Contact Information:


Atossa Genetics, Inc.
Kyle Guse
CFO and General Counsel
(O) 800-351-3902

MBS Value Partners
Matthew D. Haines (Investors)
Managing Director
(O) 212-710-9686